The current methodology, which tested both the rate of AFP elevation and its absolute value relative to that individual’s history, provides an important proof of principle for the application of Bayesian analysis in the development of a sophisticated analytical tool to provide much needed addition to ultrasound in the surveillance of HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.